Manufacturing Clinical-Grade Human Induced Pluripotent Stem Cell-Derived Beta Cells for Diabetes Treatment

0
322
Investigators focus on the key processes and guidelines for clinical translation of hPSC-derived β cells for diabetes cell therapy.
[Cell Proliferation]
Full Article